Key result
Severe COVID-19 disease is associated with reduced A-to-I editing of Alu dsRNAs, which may lead to accumulation of unedited Alu dsRNAs and increased inflammatory responses.
Observational
Answers are grounded in this paper and cite their sources.
May link reduced Alu editing to COVID-19 inflammation; hypothesis-generating and requires validation before clinical consideration.
Severe COVID-19 disease is associated with elevated inflammatory responses. One form of Aicardi–Goutières syndrome caused by inactivating mutations in ADAR results in reduced adenosine-to-inosine (A-to-I) editing of endogenous dsRNAs, induction of IFNs, IFN-stimulated genes, other inflammatory mediators, morbidity, and mortality. Alu elements, ∼10% of the human genome, are the most common A-to-I–editing sites. Using leukocyte whole-genome RNA-sequencing data, we found reduced A-to-I editing of Alu dsRNAs in patients with severe COVID-19 disease. Dendritic cells infected with COVID-19 also exhibit reduced A-to-I editing of Alu dsRNAs. Unedited Alu dsRNAs, but not edited Alu dsRNAs, are potent inducers of IRF and NF-κB transcriptional responses, IL6, IL8, and IFN-stimulated genes. Thus, decreased A-to-I editing that may lead to accumulation of unedited Alu dsRNAs and increased inflammatory responses is associated with severe COVID-19 disease.
No takes yet. Share an insight, caveat, or question.
Crooke et al. (2021) conducted an observational in Severe COVID-19 disease. Severe COVID-19 disease was evaluated on A-to-I editing of Alu dsRNAs. Severe COVID-19 disease is associated with reduced A-to-I editing of Alu dsRNAs, which may lead to accumulation of unedited Alu dsRNAs and increased inflammatory responses.
Synapse has enriched 10 related papers. Consider them for comparative context: